Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SNY compared with GSK: revenue, margins and what each company keeps, and the suppliers and customers both name
SNY
Sanofi
Change
Mkt cap
Revenue
Revenue
GSK
GSK plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
SNY
Sanofi
vs
GSK
GSK plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SNY, solid
GSK, dashed
Supply-chain overlap
Revenue flow
SNY: latest quarter not drawable. GSK: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SNY
30
REGN
Regeneron Pharmaceuticals
supplier
CYTK
Cytokinetics
supplier
BMRN
BioMarin Pharmaceutical
supplier
KYMR
Kymera Therapeutics
supplier
26 more · SNY chain
›
Shared
0
No shared counterparties.
Only GSK
18
ABBV
AbbVie
supplier
LQDA
Liquidia
customer
GPK
Graphic Packaging
supplier
INVA
Innoviva
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
14 more · GSK chain
›
SNY
Sanofi
Change
47.02
▲
+0.23%
· post 46.81
Mkt cap
$57.4B
GSK
GSK plc
Change
50.31
▼
−0.20%
· post 50.31
Closed
Nov 6 '26
Mkt cap
$108.6B
vs
Compare
Closed
Nov 6 '26
SNY
Sanofi
vs
GSK
GSK plc
47.02
▲
+0.23%
post 46.81
Price
50.31
▼
−0.20%
post 50.31
$57.4B
Mkt cap
$108.6B
Change
Change
SNY
47.02
▲
+0.23%
vs
GSK
50.31
▼
−0.20%
Closed
Nov 6 '26